Crohn’s disease is a type of inflammatory bowel disease (IBD). It primarily affects the ileum, or the end section of your small intestine. It’s also commonly found in the first section of your ...

A variety of retinal signs can occur ... Goodpasture's disease, microscopic polyangiitis and Henoch–Schönlein purpura, as well as vasculitis secondary to scleroderma and rheumatoid arthritis.

What Is White Matter Disease? White matter disease is the wearing away of tissue in the largest and deepest part of your brain. The loss of white matter function has a number of causes ...

There is evidence that Crohn’s disease is genetic, though environmental factors may also be involved. Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes inflammation in ...

This study aims to analyse and quantify the possible retinal microvascular abnormalities. Materials and methods Case–control study. Patients between 18 and 55 years old with PCR-confirmed SARS-CoV-2 ...

Here, we describe a patient with HA20, previously followed up as Behçet disease, who presented with CNS symptoms in adulthood. A 38-year-old Japanese male who had been followed up for incomplete ...

Meanwhile, talking to the Mirror, Dr. Michael Head, Senior Research Fellow in Global Health at the University of Southampton said, “Disease X is the name given to an as-yet-unknown bug, that has the ...

In the LIGHTHOUSE study, Atsena Therapeutics is evaluating ATSN-201 gene therapy for X-linked retinoschisis, leveraging AAV.SPR capsid for central retina transduction without foveal detachment risks.

Still, the thought of developing diabetic retinal disease (formerly referred to as diabetic retinopathy) was her worst nightmare. When vision problems, like eye floaters, began for her ...

Lupus vasculitis refers to inflammation that affects the blood vessels. What symptoms a person develops will depend on where in the body vasculitis occurs. Lupus vasculitis occurs when the immune ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of 2024. Word of the acquisition was first shared by Oxular’s former CEO ...

The new year is certain to bring the spread of infectious diseases – both new and old. And several factors make 2025 ripe for transmission in the U.S., including declining childhood vaccination ...